Want to see MLYS full AI Analyst Report?
Mineralys Therapeutics, Inc. (MLYS) Income Statement
Mineralys Therapeutics, Inc. Income Statement
Last quarter (Q2 2026), Mineralys Therapeutics, Inc.'s total revenue was $0.00. In Q2, Mineralys Therapeutics, Inc.'s net income was $-241.07M. See Mineralys Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 170.60M | $ 192.40M | $ 84.66M | $ 31.48M | $ 18.73M | |
| Depreciation and Amortization | $ 59.00K | $ 43.00K | $ 0.00 | $ 0.00 | $ 0.00 |
| $ -154.59M | $ -177.77M | $ -71.90M | $ -28.12M | $ -19.38M | |
| $ -170.60M | $ -192.40M | $ -84.66M | $ -31.48M | $ -18.73M | |
| $ 15.95M | $ 14.59M | $ 12.76M | $ 1.68M | $ -683.00K | |
| $ -154.65M | $ -177.81M | $ -71.90M | $ -29.80M | $ -19.41M | |
| $ -154.65M | $ -177.81M | $ -71.90M | $ -29.80M | $ -19.41M | |
| Per Share Metrics | |||||
| Basic EPS | $ -2.29 | $ -3.66 | $ -1.99 | $ -5.77 | $ -3.89 |
| Diluted EPS | $ -2.29 | $ -3.66 | $ -1.99 | $ -5.77 | $ -3.89 |
| Weighted Average Shares Outstanding | 67.66M | 48.54M | 36.19M | 5.17M | 4.98M |
| Weighted Average Shares Outstanding (Diluted) | 67.66M | 48.54M | 36.19M | 5.17M | 4.98M |
Currency in USD
